Facilitating Access to Approved Medication

Blinatumomab Injection 38.5 mcg
Blinatumomab Injection is used in adults and children to treat certain types of acute lymphocytic leukemia (ALL; a type of cancer of the white blood cells) that has not gotten better, or that has returned after treatment with other medications.

Get Access To Blinatumomab Injection 38.5 mcg

Blinatumomab specifically targets the CD19 antigen present on B cells. In December 2014, it was approved by the US Food and Drug Administration under the accelerated approval program

Blinatumomab Injection Available Price In India UK Saudi Arabia

Blinatumomab Injection

  • API – blinatumomab
  • Packaging – Glass Bottle
  • Strength – 35 mcg of lyophilized powder
  • Brand available – On Request

What is Blinatumomab Injection used for?

Blinatumomab, is a biopharmaceutical medication used as a second-line treatment for Philadelphia chromosome-negative relapsed or refractory acute lymphoblastic leukemia. It belongs to a class of constructed monoclonal antibodies, bi-specific T-cell engagers (BiTEs), that exert action selectively and direct the human immune system to act against tumor cells.


    All Trademarks and Brands that appear on website belong to their respective owners and Ikris Pharma Network does not lay and claim on them we only provide Information. We are NOT ONLINE store and We do not sell Narcotics and Sedatives. Iron Sucrose is a pharmaceutical drug that legally requires a medical prescription to be dispensed. Following Information meant for Wholesalers, Suppliers, Exporters, Doctors, Comparator Supplies, Hospitals, Generic, Brand, Corporate Sourcing, reseller, and Pharmacies.

    Get Access To Blinatumomab Injection 38.5 mcg

    Shreyaansh Lifesciences, Jaipur. India

    Shreyaansh Lifesciences is registered in Jaipur, India. Registration Number : 08AEEFS9350K1ZI under GST Act. 
    Branch Offices in India : Jaipur | New Delhi

    SF-72-73 2ND FLOOR, Jaipur Electronic Market, Ridhi Sidhi Choraha, Jaipur, Rajasthan, 302018.

    +91 99292 77766

    Facts of Medicines

    Blinatumomab Injection 38.5 mcg


    Blinatumomab Injection must be refrigerated at 2°C to 8°C (36°F to 46°F). Do not use the Blinatumomab Injection beyond the expiration date located on the carton and the vial.


    For injection: 35 mcg of lyophilized powder in a single-dose vial for reconstitution.


    The following clinically significant adverse reactions can occur with Blinatumomab Injection: Cardiovascular Toxicity, Myelosuppression, Hypersensitivity, Hypertension, Pancreatic Toxicity.


    • Genetic testing should be indicated in order to detect whether a person is at higher risk of developing hypersensitivity.
    • Blinatumomab Injection may not be added as a single agent when antiretroviral regimens are changed because of loss of the virologic response.
    • Patients with liver disease should be watchful and cautious in order to Blinatumomab Injection because it can aggravate the condition.
    • In patients with Blinatumomab Injection, conditions like immune reconstitution inflammatory syndrome, a change in body fat as well as an increased risk of heart attack may occur.
    • Blinatumomab Injection is not recommended for use in infants who are under 3 months of age.
    • Cases like lactic acidosis and severe hepatomegaly with steatosis occurred with the use of nucleoside analogues.
    • Sometimes serious hypersensitivity reactions have been associated with Blinatumomab Injection.

    FAQs – Medicine Questions

    Blinatumomab Injection 38.5 mcg
    Is blinatumomab considered chemotherapy?
    Blincyto (blinatumomab) is used to treat cancer but it is not chemotherapy. Drugs that are used to treat cancer are called anticancer drugs. Blincyto is a monoclonal antibody that is a targeted therapy anticancer drug
    What is blinatumomab used for?
    Blinatumomab is used in adults and children to treat certain types of acute lymphocytic leukemia (ALL; a type of cancer of the white blood cells) that has not gotten better, or that has returned after treatment with other medications.
    Is blinatumomab an antibody?
    Blinatumomab (Blincyto, Amgen), a bi-specific antibody, is a first-in-class, targeted immunotherapy agent for treatment of B-cell malignancies with a novel mechanism of action which involves in-vivo engagement of the patient’s T cells with CD19-expressing tumour cells.
    Where can I buy Blinatumomab Injection?

    You can buy Blinatumomab Injection from any authorized whole-seller after getting a prescription from a qualified doctor. It is always better to check the credential of the whole-seller/supplier/exporter before buying the product.

    The buyer should check the existing law in their home country before importing the product.

    What is the procedure to buy Blinatumomab Injection?

    Patients can simply fill the order form or can send mail at info@treatmentoptions4u.com. Patients can also send WhatsApp messages to +91 99292 77766 / 98738 10020   We will reply ASAP with the details of the Blinatumomab Injection price as well as procurement procedure.

    Note:- The order will be confirmed only after the receipt of the Valid prescription of the Clinician.

    How effective is blinatumomab?
    Those treated with blinatumomab also did substantially better on a measure known as event-free survival: 69% versus 43%. An event was defined as a relapse of their cancer, death, diagnosis of a second cancer, or failure to achieve complete remission. Overall survival also favored the blinatumomab group